Royce & Associates LP Voyager Therapeutics, Inc. Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$8.05 - $14.21 $13,990 - $24,696	-1,738 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$6.8 - $14.66 $1,373 - $2,961	202 Added 13.15%	1,738 $16,000
Q4 2019 Feb 06, 2020	BUY	$12.82 - $16.85 $1,487 - $1,954	116 Added 8.17%	1,536 $21,000
Q3 2019 Nov 13, 2019	BUY	$16.31 - $28.29 $23,160 - $40,171	1,420 New	1,420 $24,000

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.